Mimetogen Pharmaceuticals - Mimetogen Pharmaceuticals

Mimetogen Pharmaceuticals corporate overview, management, board, advisors, mimetics technology, RD, clinical development, corporate communications

OVERVIEW

The site mimetogen.com currently has a traffic ranking of zero (the smaller the more users). We have examined thirteen pages within the domain mimetogen.com and found seven websites referring to mimetogen.com. We were able to detect two contacts and addresses for mimetogen.com to help you connect with them. We were able to detect one social network sites owned by mimetogen.com. The site mimetogen.com has been on the internet for nine hundred and ninety-one weeks, one day, six hours, and fifty-five minutes.
Pages Crawled
13
Links to this site
7
Contacts
2
Addresses
2
Social Links
1
Online Since
Jul 2005

MIMETOGEN.COM TRAFFIC

The site mimetogen.com has seen varying quantities of traffic all over the year.
Traffic for mimetogen.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for mimetogen.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for mimetogen.com

Date Range

All time
This Year
Last Year
Last Month

MIMETOGEN.COM HISTORY

The site mimetogen.com was registered on July 05, 2005. It was updated on the date of April 08, 2014. This domain will go back on the market on the date of July 05, 2015. It is now nine hundred and ninety-one weeks, one day, six hours, and fifty-five minutes young.
REGISTERED
July
2005
UPDATED
April
2014
EXPIRED
July
2015

DOMAIN SPAN

19
YEARS
0
MONTHS
0
DAYS

LINKS TO DOMAIN

Farmacologia Oculare - Farmaci e Occhio

Please contact your service provider for more details.

MSBi Valorisation Inc.

MSBi Valorisation fait fructifier la recherche de pointe au Québec. MSBi Valorisation contribue au développement économique du Québec. 150 emplois hautement qualifiés créés au Québec.

Schooner Capital

Schooner Capital is a Boston-based private investment firm focused on growth equity and alternative asset investments. We have no outside limited partners and approach all investments with a long-term perspective.

Bienvenue ! Aligo

COMMENT NOUS TRAITONS NOS DOSSIERS. La recherche de pointe au quebec. La recherche de pointe au quebec. La recherche de pointe au quebec. Aligo Innovation est une société de valorisation universitaire Québecoise provenant du regroupement des sociétés Gestion Valeo et de MSBI Valorisation. Aligo valorise les actifs de propriété intellectuelle de ses partenaires institutionnels. Vous retrouverez dans cet onglet toutes les technologies disponibles pour license.

WHAT DOES MIMETOGEN.COM LOOK LIKE?

Desktop Screenshot of mimetogen.com Mobile Screenshot of mimetogen.com Tablet Screenshot of mimetogen.com

CONTACTS

Mimetogen Pharmaceuticals

Garth Cumberlidge

1000 de La Gauchetière Street West, Suite 900

Montreal, QC, H3B 5H4

CA

Webcore Labs Inc.

Domain Help

72026, 1600 - 90 Avenue SW

Calgary, AB, T2V 5H9

CA

MIMETOGEN.COM SERVER

We discovered that the main page on mimetogen.com took one thousand four hundred and fifty-three milliseconds to download. We could not discover a SSL certificate, so in conclusion our web crawlers consider this site not secure.
Load time
1.453 secs
SSL
NOT SECURE
Internet Protocol
198.27.102.53

NAME SERVERS

ns1.webcorelabs.com
ns2.webcorelabs.com

BROWSER IMAGE

SERVER OS

We detected that this website is weilding the nginx server.

HTML TITLE

Mimetogen Pharmaceuticals - Mimetogen Pharmaceuticals

DESCRIPTION

Mimetogen Pharmaceuticals corporate overview, management, board, advisors, mimetics technology, RD, clinical development, corporate communications

PARSED CONTENT

The site mimetogen.com had the following on the homepage, "Mimetogen Pharmaceuticals Enters Into Licensing Agreement with Allergan to Develop and Commercialize Tavilermide MIM-D3." We noticed that the website said " Mimetogen Pharmaceuticals Announces Topline Results of Its Second Clinical Study with MIM-D3 for the Treatment of Dry Eye Syndrome." It also stated " Mimetogen Pharmaceuticals Announces Expiration of Exclusive Option Agreement with Bausch Lomb. Announces Initiation of a Phase 3 Clinical Trial with MIM-D3 to Treat Dry Eye Syndrome. To successfully advance the development ." The header had Biotech as the highest ranking keyword. This keyword was followed by Biotechnology, Drug Development, and Ophthalmology Dry Eye Syndrome which isn't as urgent as Biotech. The other words the site used was DES Keratoconjunctivitis sicca Glaucoma. Neuroprotection MIM-D3 is also included but could not be viewed by search parsers.

ANALYZE MORE DOMAINS

Mimetolith Just another WordPress.com weblog

The Great Square has no corners. The Great Square has no corners. A lost corner is defined as a point of a survey whose position cannot be determined by the original monument or by acceptable evidence as to where the original monument was. As he looked at the computer screen, he lowere.

MIMEtoLITHs MoViE

Algis Kemezys is a seasoned image maker both in still photography and video. His photography has been exhibited worldwide while his mostly-documentary videos have played in international festivals and won prizes. 8th Panorama of Independent Cinematographers Docum. Best Documentary Award for Mimetoliths. MIMETOLITHS, a new 60-minute documentary by Montre. MIMETOLITHS - short synopsis This film trave. Tuesday, July 24, 2007. Thursday, April 05, 2007.

Dark Red Lovely Sunset. love isnt only in fairytailes!

Да бъдеш щастлив не означава да имаш идеален живот. Да бъдеш щастлив означава да си влюбен в живота, въпреки всички предизвикателства, загуби и разочарования. Да бъдеш щастлив означава да не бъдеш жертва на проблемите си, а да се превърнеш в автор на житейската си история. Да бъдеш щастлив е завоевание, а не дело на случайността. Неделя, 4 октомври 2015 г. Поредното прекрасно събитие през годината - Спектакълът на Lord of the dance. Неделя, октомври 04, 2015.

MimeBlog 默客部落

仮面 KAMEN 日本默劇大師 清水潔 默劇作品. 2009年日本動畫短片大賽 第十一回 TBS DigiCon6 大賞 得獎人黃麗明.